Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_assertion type Assertion NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_head.
- NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_assertion description "[There is still no concensus about the use of the immunosuppression superimposed upon conventional insulin therapy in early diagnosed IDDM and the follow-up of the relatives of IDDM patients who share the genetic predisposition and serological markers for the risk of future onset of IDDM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_provenance.
- NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_assertion evidence source_evidence_literature NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_provenance.
- NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_assertion SIO_000772 2519348 NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_provenance.
- NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_assertion wasDerivedFrom befree-2016 NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_provenance.
- NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_assertion wasGeneratedBy ECO_0000203 NP1217404.RAXBUJjiU9I-s_WKWlm5Y2-5UetPY6RrU8SepCzGndeB4130_provenance.